Sg Americas Securities, LLC Voyager Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 12,340 shares of VYGR stock, worth $71,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,340

Previous 10,780 14.47%

Holding current value

$71,325

Previous $85,000 15.29%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$5.77 - $9.27 $9,001 - $14,461	1,560 Added 14.47%	12,340 $72,000
Q2 2024 Jul 12, 2024	BUY	$7.42 - $10.54 $79,987 - $113,621	10,780 New	10,780 $85,000
Q2 2021 Aug 12, 2021	SELL	$3.94 - $5.44 $498,804 - $688,704	-126,600 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.61 - $9.04 $583,626 - $1.14 Million	126,600 New	126,600 $596,000
Q4 2020 Feb 04, 2021	SELL	$7.15 - $12.28 $67,124 - $115,284	-9,388 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$10.01 - $13.75 $137,417 - $188,760	-13,728 Reduced 59.39%	9,388 $100,000
Q2 2020 Jul 20, 2020	BUY	$8.05 - $14.21 $18,780 - $33,151	2,333 Added 11.23%	23,116 $292,000
Q1 2020 Apr 30, 2020	BUY	$6.8 - $14.66 $141,324 - $304,678	20,783 New	20,783 $190,000
Q3 2019 Nov 04, 2019	SELL	$16.31 - $28.29 $892,825 - $1.55 Million	-54,741 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$19.18 - $27.88 $242,396 - $352,347	-12,638 Reduced 18.76%	54,741 $1.49 Million
Q1 2019 Apr 29, 2019	BUY	$8.0 - $19.66 $49,632 - $121,970	6,204 Added 10.14%	67,379 $1.29 Million
Q4 2018 Feb 01, 2019	BUY	$8.59 - $18.05 $425,016 - $893,077	49,478 Added 423.0%	61,175 $575,000
Q3 2018 Nov 06, 2018	SELL	$17.11 - $21.74 $369,319 - $469,257	-21,585 Reduced 64.85%	11,697 $221,000
Q2 2018 Aug 07, 2018	BUY	$16.76 - $23.92 $557,806 - $796,105	33,282 New	33,282 $650,000
Q1 2018 May 03, 2018	SELL	$16.16 - $31.31 $115,010 - $222,833	-7,117 Closed	0 $0
Q4 2017 Jan 24, 2018	SELL	$12.26 - $25.88 $256,381 - $541,202	-20,912 Reduced 74.61%	7,117 $118,000
Q3 2017 Nov 07, 2017	BUY	$8.37 - $20.59 $234,602 - $577,117	28,029	28,029 $577,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Voyager Therapeutics, Inc. Transaction History